In the BioHarmony Drug Report Database
Fomivirsen
Vitravene (fomivirsen) is an oligonucleotide pharmaceutical. Fomivirsen was first approved as Vitravene on 1998-08-26. It is used to treat cytomegalovirus retinitis in the USA.
Trade Name
|
Vitravene |
|---|---|
Common Name
|
fomivirsen |
ChEMBL ID
|
CHEMBL1201688 |
Indication
|
cytomegalovirus retinitis |
Drug Class
|
Antisense oligonucleotides: antivirals |
Image (chem structure or protein)